Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
about
Prospective evaluation of the '4Ts' score and particle gel immunoassay specific to heparin/PF4 for the diagnosis of heparin-induced thrombocytopenia.Heparin-induced thrombocytopenia in patients requiring prolonged intensive care unit treatment after cardiopulmonary bypass.Anti-heparin/platelet factor 4 antibody optical density values and the confirmatory procedure in the diagnosis of heparin-induced thrombocytopeniaEffect of anti-platelet factor-4/heparin antibody induction on early saphenous vein graft occlusion after coronary artery bypass surgery.Validation of the high-dose heparin confirmatory step for the diagnosis of heparin-induced thrombocytopenia.Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis.Frequency of heparin/platelet factor 4-dependent platelet antibodies in patients undergoing angioplasty and stenting for cardiovascular disease and their role for on-clopidogrel platelet reactivity.Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Improving the specificity of the PF4 ELISA in diagnosing heparin-induced thrombocytopenia.Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.Anti-PF4/heparin antibodies and venous graft occlusion in postcoronary artery bypass surgery patients randomized to postoperative unfractionated heparin or fondaparinux thromboprophylaxis.Contributions of biological tests and the 4 Ts score in the diagnosis of heparin induced thrombocytopenia.Production of Anti-platelet Factor 4/Heparin Complex Antibodies After Cardiovascular Surgery.Atherosclerosis is not a risk factor for anti-platelet factor 4/heparin antibody formation after cardiopulmonary bypass surgery.Ten-year screening for thrombocytopenia after aortic valve replacement.Prospective evaluation of a rapid nanoparticle-based lateral flow immunoassay (STic Expert(®) HIT) for the diagnosis of heparin-induced thrombocytopenia.Clinical and laboratory characteristics associated with a high optical density anti-platelet factor 4 ELISA testProtamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies.The association of anti-platelet factor 4/heparin antibodies with early and delayed thromboembolism after cardiac surgery.Flow cytometric analysis of platelet cyclooxygenase-1 and -2 and surface glycoproteins in patients with immune thrombocytopenia and healthy individuals.Superficial vein thrombosis.Considerations for drug dosing post coronary artery bypass graft surgery.Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study
P2860
Q33374563-77CDC890-91E3-49AA-8BBA-9969D85A41AEQ33377839-71F064B7-03EC-4C30-B229-F19E4A2FA413Q33381447-F749AF0A-F41B-4A77-99B1-F1ADEC5D20BFQ33385134-BC686B82-E89E-4645-A540-A14D35B3DE29Q33389839-81CDAA08-7BD3-4B29-8084-BB2405CF0845Q33392854-A76CD0B8-F8A8-4FAB-9182-B3A378DB596BQ33399119-334A6F3A-08DB-44B0-8303-DA586A1E9BE7Q33399580-E15373B2-EAF5-49C5-8294-920B3FC00AB2Q33401466-464C9F6D-303C-4238-9F76-45C8A3623A74Q33403113-D4CB68FF-6084-4F7D-A23E-09A788305FEFQ33404709-98AB6CA8-2F34-4A1C-A4B5-9A8180C02FE2Q33405248-7B251310-CA5B-4237-9FEB-2F9C62D9DFD5Q33411333-2F382800-99B3-43BF-A1AF-4C561A3C2D54Q33413033-23127F53-5FC8-4D46-BEBE-A73433110540Q33413153-FDF7D339-99D3-4CC6-A031-F473818123C1Q33415202-F4E47C61-39D2-4284-BD59-BA2B5A700EC1Q33428198-501779B4-8F5C-4B47-A876-5A79A10F193EQ33433633-0733B268-0AE6-4D4A-876F-FAED9ADE078FQ33435819-35A714F8-42FE-4462-8127-65342C55EFB9Q33435826-E8FA1772-645C-4DD0-9990-C753261CD75BQ43905870-B115E457-54F0-458D-AE8F-3C1E84996380Q46731532-828D42DB-5C73-44A8-AEBE-1BD4DB6B748FQ47630566-ABE67547-EF18-4FEA-8627-5C2C9F82328FQ58375689-57B2C50B-7DD8-43D1-AADD-02BE0DDEFFCE
P2860
Changes in platelet count after cardiac surgery can effectively predict the development of pathogenic heparin-dependent antibodies.
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Changes in platelet count afte ...... heparin-dependent antibodies.
@ast
Changes in platelet count afte ...... heparin-dependent antibodies.
@en
type
label
Changes in platelet count afte ...... heparin-dependent antibodies.
@ast
Changes in platelet count afte ...... heparin-dependent antibodies.
@en
prefLabel
Changes in platelet count afte ...... heparin-dependent antibodies.
@ast
Changes in platelet count afte ...... heparin-dependent antibodies.
@en
P2093
P2860
P1476
Changes in platelet count afte ...... heparin-dependent antibodies.
@en
P2093
Claire Pouplard
Jacques Fusciardi
Marc Antoine May
Michel Marchand
Sandra Regina
Yves Gruel
P2860
P304
P356
10.1111/J.1365-2141.2005.05381.X
P407
P577
2005-03-01T00:00:00Z